CD40 ligand has potent antiviral activity
- 1 May 1995
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 1 (5) , 437-441
- https://doi.org/10.1038/nm0595-437
Abstract
For B cells to make antibodies against most antigens, they require help from T cells. T cell help is delivered as two signals to the B cell, one of which is via CD40 and the other can be through receptors for any of a variety of soluble cytokines. We have constructed recombinant vaccinia viruses that express the ligand for CD40 and have shown that the growth of these viruses is dramatically controlled in vivo, even in mice that lack T or B cells. In this paper, we also described our attempts to analyse the CD40 ligand-mediated antiviral activity by studying the clearance of these viruses in mice that are deficient in important antiviral mechanisms. Thus, the antiviral activity of CD40L may represent a surprising and potent effector mechanism of T cells activated during a virus infection.Keywords
This publication has 33 references indexed in Scilit:
- CD40 ligand and its role in X-linked hyper-IgM syndromeImmunology Today, 1993
- Induction of human IgE synthesis in B cells by mast cells and basophilsNature, 1993
- Non-antigen signals for B-cell growth and differentiation to antibody secretionCurrent Opinion in Immunology, 1993
- Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation.The Journal of Experimental Medicine, 1993
- Immune Response in Mice that Lack the Interferon-γ ReceptorScience, 1993
- Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion.The Journal of Experimental Medicine, 1992
- Molecular and biological characterization of a murine ligand for CD40Nature, 1992
- The SCID Mouse Mutant: Definition, Characterization, and Potential UsesAnnual Review of Immunology, 1991
- The immunobiology of murine interleukin-1α encoded by recombinant vaccinia virusCytokine, 1991